Recent News

• 12.11.2025 - Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
• 12.08.2025 - Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
• 12.05.2025 - Iridex to Present at the Sidoti Year-End Virtual Investor Conference
• 11.11.2025 - Iridex Reports Third Quarter 2025 Financial Results
• 10.28.2025 - Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Recent Filings

• 12.11.2025 - EX-99.1 EX-99.1
• 12.11.2025 - 8-K Current report
• 12.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.12.2025 - 8-K Current report